AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (418 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Commentary | Open Access

Beta blockers in critical illness: promising but appropriate subphenotyping is needed

Luyao Zhang1 , Lu Ke2,3 ( )
Department of Pathology and Pathophysiology, School of Medicine, Nanjing University of Chinese Medicine, No. 138 Xianlin Road, Qixia District, Nanjing 210023, Jiangsu, China
Department of Critical Care Medicine, Jinling Hospital, Medical School of Nanjing University, No. 305 Zhongshan East Road, Xuanwu District, Nanjing 210002, Jiangsu, China
National Institute of Healthcare Data Science, Nanjing University, No. 22 Hankou Road, Gulou Distrcit, Nanjing 210010, Jiangsu, China
Show Author Information

References

【1】
【1】
 
 
Burns & Trauma
Article number: tkae060

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Zhang L, Ke L. Beta blockers in critical illness: promising but appropriate subphenotyping is needed. Burns & Trauma, 2024, 12: tkae060. https://doi.org/10.1093/burnst/tkae060

3

Views

0

Downloads

0

Crossref

0

Web of Science

1

Scopus

Received: 15 June 2024
Revised: 26 August 2024
Accepted: 28 August 2024
Published: 10 October 2026
© The Author(s) 2024. Published by Oxford University Press.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com